NY Times

DECEMBER 11, 2020

British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.

Allergies 145

Allergies Vaccine Vaccination Clinical Trials 145

Pharmaceutical Technology

NOVEMBER 23, 2023

The fast track designation for the paediatric multi-food allergy therapy ADP101 was based on the Phase I/II data.

Allergies 147

Allergies 147

Pharmaceutical Technology

OCTOBER 10, 2024

According to Lancet Public Health, the incidence of probable food allergy more than doubled in England between 2008 and 2018.

Allergies 130

Allergies 130

Pharmaceutical Technology

DECEMBER 2, 2024

CBC Group has completed the strategic acquisition of UCB's mature neurology and allergy business in China for $680m.

Allergies 130

Allergies 130

Pharmaceutical Technology

DECEMBER 2, 2024

The EMA’s CHMP has endorsed expanding the use of Palforzia to toddlers aged one to three years with peanut allergies.

Allergies 130

Allergies 130

Pharmaceutical Technology

AUGUST 27, 2024

UCB has entered a divestment agreement in China to sell its mature neurology and allergy business to CBC Group and Mubadala for $680m.

Allergies 130

Allergies 130

Pharmaceutical Technology

MAY 16, 2024

IgGenix is planning to initiate a clinical trial later this year investigating its peanut allergy monoclonal antibody IGXN001.

Allergies 147

Allergies Clinical Trials Clinical Trials Antibody 147

Bio Pharma Dive

AUGUST 31, 2020

The Swiss firm will take over the launch of Aimmune's Palforzia, sales of which have disappointed since its approval in January.

Allergies 284

Allergies Sales 284

Fierce Pharma

FEBRUARY 16, 2024

People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades. People with food allergies finally have a drug that can help prevent severe outcomes—and it’s a drug that’s been on the market for two decades.

Allergies 139

Allergies FDA Approval Marketing Medicine 139

Pharma Times

FEBRUARY 10, 2022

Research demonstrates that people who live with peanut allergies face isolation and discrimination

Allergies 123

Allergies Research 123

Pharmaceutical Technology

DECEMBER 26, 2024

Allergen for Grass Pollen Allergy is under clinical development by Roxall Medizin and currently in Phase II for Grass Pollen Allergy.

Allergies 100

Allergies Clinical Development Development 100

pharmaphorum

DECEMBER 23, 2021

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. billion last year, is also developing immunotherapies for other indications including egg and multi-tree nut allergies.

Allergies 124

Allergies Drugs Clinical Trials Clinical Trials 124

Pharmaceutical Technology

DECEMBER 20, 2023

The FDA accepted the filing based on NIH-funded Phase III trial interim results, with an approval decision expected in Q1 2024

Allergies 244

Allergies Trials 244

pharmaphorum

FEBRUARY 19, 2024

Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people with food allergies in the US.

Allergies 126

Allergies Medicine Drugs 126

pharmaphorum

OCTOBER 10, 2022

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. per person being spent on food allergy research. Luckily for those with food allergies, the food allergy sector has benefitted from this influx of funding.

Allergies 111

Allergies Marketing Production Doctor 111

Pharma Times

MAY 12, 2022

The study is the UK’s most comprehensive allergy test, analysing 295 allergens, including well known potential food allergens

Allergies 131

Allergies Development 131

Fierce Pharma

DECEMBER 19, 2023

On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes. | On the market for two decades for asthma, Novartis and Roche’s Xolair is closing in on a new indication as a way for those with food allergies to avoid severe outcomes.

Allergies 123

Allergies Marketing 123

BioTech 365

JUNE 13, 2025

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress – Rademikibart … Continue reading →

Allergies 52

Allergies 52

Medical Xpress

MAY 3, 2023

A new Nature Immunology study led by University of Pittsburgh and National Institutes of Health researchers sheds light on how a rare type of helper T cell, called Th9, can drive allergic disease, suggesting new precision medicine approaches to treating allergies in patients with high levels of Th9.

Allergies 124

Allergies Medicine Research 124

Bio Pharma Dive

JULY 18, 2022

The food giant will pay French company Enterome about $40 million to join in the development of an inflammatory bowel disease drug as well as other food allergy treatments.

Allergies 261

Allergies Drugs Development 261

BioTech 365

JUNE 15, 2025

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial … Continue reading →

Allergies 52

Allergies Trials 52

XTalks

OCTOBER 6, 2022

According to the Asthma and Allergy Foundation of America, about 32 million people in the US have food allergies, which means allergy friendly food brands not only have a large audience base, but are also necessities. Partake Foods has become one of the most popular allergy friendly food brands and it recently secured $11.5

Allergies 90

Allergies Branding Production Packaging 90

Outsourcing Pharma

SEPTEMBER 16, 2021

The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies.

Allergies 105

Allergies FDA Approval Drugs Regulation 105

Medical Xpress

MAY 9, 2023

Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide variety of medical equipment that can contain the allergen.

Allergies 105

Allergies Containment 105

Bio Pharma Dive

AUGUST 22, 2022

Fauci will leave his post as the director of the National Institute of Allergy and Infectious Diseases and as the president’s chief medical advisor.

Allergies 246

Allergies 246

NPR Health - Shots

APRIL 2, 2023

Patients who have digestive symptoms only after eating red meat may have developed an allergy caused by ticks. Previously, doctors looked for symptoms such as rashes, hives and breathing troubles. Image credit: Getty Images)

Allergies 118

Allergies Doctor Doctors Development 118

Medical Xpress

APRIL 4, 2023

Children with food allergies might experience heightened anxiety over social situations involving food. A Baylor College of Medicine psychologist explains how parents can alleviate this stress while teaching them to be mindful of their allergies.

Allergies 96

Allergies Medicine 96

Medical Xpress

NOVEMBER 28, 2022

Philip Li from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has pioneered a new nurse-led penicillin allergy triage and testing strategy—the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI), and demonstrated its effectiveness and safety compared to traditional allergy testing.

Allergies 98

Allergies Nurses Medicine Drugs 98

Scienmag

JULY 5, 2022

Scientists have revealed the genetic and molecular structure of key molecules linked to the sometimes life-threatening mammalian-meat allergy brought on by tick bites. The […].

Allergies 98

Allergies Genetics Scientist Research 98

XTalks

FEBRUARY 26, 2024

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. However, the treatment is restricted to peanut allergy.

Allergies 100

Allergies FDA Approval Drugs Protein 100

Rethinking Clinical Trials

MARCH 18, 2025

ABATE Infection was supported within the NIH Collaboratory by the National Institute of Allergy and Infectious Diseases. Universal decolonization for all hospitalized adults in non-ICU settings was cost-effective in some scenarios. Read the full report. Learn more about ABATE Infection.

Allergies 148

Allergies Trials Clinical Trials Clinical Trials 148

Pharmaceutical Technology

APRIL 20, 2023

Following a tumultuous development cycle, DBV Technologies will now have to conduct an additional safety study of its peanut allergy Viaskin patch in toddlers ages 1–3 years, based on written correspondence from the US Food and Drug Administration (FDA). However, the French company will not be required to run a further efficacy study.

Allergies 130

Allergies Trials Immune Response Licensing 130

Medical Xpress

JANUARY 31, 2025

Their potential to suppress allergic reactions and offer new approaches to allergy treatment is particularly promising. The results indicate that -glucans can target the immune system and modulate pro-inflammatory responses. The research was published in the International Journal of Molecular Sciences.

Allergies 94

Allergies Bacteria Research 94

Outsourcing Pharma

AUGUST 29, 2024

The European Commission has approved ARS Pharmaceuticalsâ adrenaline nasal spray for the emergency treatment of severe allergies, EURneffy.

Allergies 92

Allergies Drug Delivery Drugs 92

pharmaphorum

DECEMBER 10, 2020

Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Allergies 103

Allergies Vaccine Vaccination Regulation 103

Scienmag

JANUARY 20, 2022

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

Allergies 98

Allergies Trial Funding Clinical Trials Clinical Trials 98

XTalks

JUNE 21, 2021

who is on a mission to help parents save their children from food allergies by providing them with a powder added to their milk bottles. Zakowski started this company because his nephew developed several severe food allergies. Related: Red Meat Allergy Test Gets FDA Clearance. The product is part of a three-step guidance system.

Allergies 98

Allergies Production FDA Approval Protein 98